Literature DB >> 1689739

Presence of galanin-like immunoreactivity in nontumorous corticotrophs and corticotroph adenomas of the human pituitary.

M E Vrontakis1, T Sano, K Kovacs, H G Friesen.   

Abstract

Galanin is a 29-amino acid neuropeptide widely distributed in the central nervous system. Galanin-like immunoreactivity (galanin-LI) was investigated in 23 nontumorous human adenohypophyses and 27 pituitary adenomas. Galanin-LI was demonstrated by immunohistochemistry on formalin-fixed paraffin-embedded sections, using the avidin-biotin-peroxidase complex method. All 23 nontumorous pituitaries showed the presence of galanin-positive cells which were similar to the corticotrophs in shape, size, histological features, and distribution. Immunoreactivity based on the study of mirror sections was found to be present in the cytoplasm of corticotrophs, indicating that galanin-LI colocalizes with ACTH. Crooke's cells and basophilic cells spreading to the posterior lobe (basophil invasion) were also positive for galanin. No galanin-LI was seen in lactotrophs of the human pituitaries, including 4 estrogen-treated men and 4 pregnant women. Varying numbers of tumor cells in 13 of 18 corticotroph adenomas were positive for galanin. Galanin-LI and ACTH were coexpressed in the cytoplasm of the same adenoma cells. In 19 pituitary adenomas composed of cells other than corticotrophs, no galanin-LI was noted. This study is the first report providing evidence of the presence of galanin-LI in corticotrophs of the human pituitary.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689739     DOI: 10.1210/jcem-70-3-747

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  Galanin.

Authors:  M E Vrontakis; A Torsello; H G Friesen
Journal:  J Endocrinol Invest       Date:  1991-10       Impact factor: 4.256

2.  Immunohistochemical distribution of regulatory peptides in the human fetal adenohypophysis.

Authors:  R Reyes; F Valladares; R Gutiérrez; M González; A R Bello
Journal:  J Anat       Date:  2008-06       Impact factor: 2.610

3.  Galanin-like immunoreactivity is increased in the brain of estradiol- and methyltestosterone-treated eels.

Authors:  M Olivereau; J Olivereau
Journal:  Histochemistry       Date:  1991

4.  Corticotroph (Basophil) invasion of the pars nervosa in the human pituitary: Localization of proopiomelanocortin peptides, galanin and peptidylglycine α-amidating monooxygenase-like immunoreactivities.

Authors:  Ricardo V Lloyd; Constance J D'Amato; Michelle T Thiny; Long Jin; Samuel P Hicks; William F Chandler
Journal:  Endocr Pathol       Date:  1993-06       Impact factor: 3.943

5.  Galanin positively modulates prolactin secretion in normal women.

Authors:  S Grottoli; E Arvat; L Gianotti; J Ramunni; L Di Vito; B Maccagno; E Ciccarelli; F Camanni; E Ghigo
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

Review 6.  Galanin and its receptors in neurological disorders.

Authors:  Linda Lundström; Anna Elmquist; Tamas Bartfai; Ulo Langel
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

7.  Coexpression of galanin and adrenocorticotropic hormone in human pituitary and pituitary adenomas.

Authors:  D W Hsu; S C Hooi; E T Hedley-Whyte; R M Strauss; L M Kaplan
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

8.  Modulation of galanin and neuromedin U-like immunoreactivity in rat corticotropes after alteration of endocrine status.

Authors:  V Cimini; S Van Noorden; C M Timson; J M Polak
Journal:  Cell Tissue Res       Date:  1993-04       Impact factor: 5.249

9.  The Immunophenotype of Pituitary Adenomas.

Authors:  Ricardo V. Lloyd; Bernd W. Scheithauer; Kalman Kovacs; Patrick C. Roche
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

10.  Galanin System in Human Glioma and Pituitary Adenoma.

Authors:  Sarah Falkenstetter; Julia Leitner; Susanne M Brunner; Tim N Rieder; Barbara Kofler; Serge Weis
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-24       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.